Newbury Pharmaceuticals (Sweden) Top Management
NEWBRY Stock | 3.44 0.08 2.38% |
Newbury Pharmaceuticals employs about 6 people. The company is managed by 5 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.2 employees per reported executive. Analysis of Newbury Pharmaceuticals' management performance can provide insight into the company performance.
Andrea Karnitschky Insider Sr Devel |
Fredrik Hellqvist Insider VP Marketing |
Newbury |
Newbury Pharmaceuticals Workforce Comparison
Newbury Pharmaceuticals AB is regarded third in number of employees category among its peers. The total workforce of Drug Manufacturers-Specialty & Generic industry is now estimated at about 24.0. Newbury Pharmaceuticals totals roughly 6.0 in number of employees claiming about 25% of equities under Drug Manufacturers-Specialty & Generic industry.
The company has Profit Margin (PM) of (2.89) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.75) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.75. Newbury Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Newbury Pharmaceuticals Price Series Summation is a cross summation of Newbury Pharmaceuticals price series and its benchmark/peer.
Newbury Pharmaceuticals Notable Stakeholders
A Newbury Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Newbury Pharmaceuticals often face trade-offs trying to please all of them. Newbury Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Newbury Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Andrea Karnitschky | Sr Devel | Profile | |
Fredrik Hellqvist | VP Marketing | Profile | |
Karl Karlsson | Founder Chairman | Profile | |
Lars Minor | Chief Officer | Profile | |
Christoffer Tell | Chief Officer | Profile |
About Newbury Pharmaceuticals Management Performance
The success or failure of an entity such as Newbury Pharmaceuticals often depends on how effective the management is. Newbury Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Newbury management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Newbury management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Newbury Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Newbury Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Newbury Pharmaceuticals' management manipulating its earnings.
Newbury Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Newbury Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Newbury Pharmaceuticals within its industry.Newbury Pharmaceuticals Manpower Efficiency
Return on Newbury Pharmaceuticals Manpower
Revenue Per Employee | 962.3K | |
Revenue Per Executive | 1.2M |
Complementary Tools for Newbury Stock analysis
When running Newbury Pharmaceuticals' price analysis, check to measure Newbury Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newbury Pharmaceuticals is operating at the current time. Most of Newbury Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newbury Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newbury Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newbury Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |